The European Union has criticised the UK's rapid approval of Pfizer and BioNTech's Covid-19 vaccine, saying its own procedure was more thorough.
The move to grant emergency authorisation to the Pfizer/BioNTech was made under an ultra-fast, emergency approval process, which allowed the British drugs regulator to temporarily authorise the vaccine only ten days after it began examining data from large-scale trials.
In an unusually blunt statement, the European Medicines Agency (EMA), which is in charge of approving Covid-19 vaccines for the EU, said its longer approval procedure was more appropriate as it was based on more evidence and required more checks than the emergency procedure chosen by Britain.
Read more on rte.ie